1. The role of peptides in reversing chemoresistance of breast cancer: current facts and future prospects
    Yongxiu Huang et al, 2023, Frontiers in Pharmacology CrossRef
  2. miRNA interplay: Mechanisms and therapeutic interventions in cancer
    Zehua Wang et al, 2024, MedComm – Oncology CrossRef
  3. Targeting Histone Modifications in Breast Cancer: A Precise Weapon on the Way
    Wei Li et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  4. NT21MP negatively regulates paclitaxel-resistant cells by targeting miR‑155‑3p and miR‑155-5p via the CXCR4 pathway in breast cancer
    Yueyue Wang et al, 2018, International Journal of Oncology CrossRef

  5. Long Non-Coding RNA UCA1 Modulates Paclitaxel Resistance in Breast Cancer via miR-613/CDK12 Axis


    Chunhong Liu et al, 2020, Cancer Management and Research CrossRef
  6. Inhibition of FBP1 expression by KMT5A through TWIST1 methylation is one of the mechanisms leading to chemoresistance in breast cancer
    Xue Peng et al, 2024, Oncology Reports CrossRef
  7. Upregulation of miR‑335 exerts protective effects against sepsis‑induced myocardial injury
    Xian Long et al, 2021, Molecular Medicine Reports CrossRef
  8. Lysine Methyltransferase 5A Promotes the Progression of Growth Hormone Pituitary Neuroendocrine Tumors through the Wnt/β-Catenin Signaling Pathway
    Junjun Li et al, 2024, Neuroendocrinology CrossRef
  9. Role of non-coding RNAs in modulating the response of cancer cells to paclitaxel treatment
    Soudeh Ghafouri-Fard et al, 2021, Biomedicine & Pharmacotherapy CrossRef